Sector
PharmaceuticalsOpen
₹519.9Prev. Close
₹513.05Turnover(Lac.)
₹5,506.16Day's High
₹552.6Day's Low
₹519.952 Week's High
₹74552 Week's Low
₹330.9Book Value
₹143.29Face Value
₹5Mkt Cap (₹ Cr.)
1,688.44P/E
39.34EPS
13.59Divi. Yield
0.1910 Jul 2024
12:00 AM
EGM
17 Sep 2024
12:00 AM
AGM
Announcement Date: 17 Sep, 2024
20 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
Here are some of the stocks that may see significant price movement today: BHEL, IRCTC, Birlasoft, Bajaj Healthcare, etc.
Earlier this year, Bajaj Healthcare secured formal CMO agreements with customers in the United Kingdom and the European Union to deliver 15 APIs.
The strategic partnership aims to enhance Bajaj Healthcare's presence in the European pharmaceutical market.
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 13.8 | 13.8 | 13.8 | 13.8 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 264.56 | 353.89 | 314.69 | 244.61 |
Net Worth | 278.36 | 367.69 | 328.49 | 258.41 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Revenue | 656.98 | 410 | 370.17 | 327.1 |
yoy growth (%) | 60.23 | 10.76 | 13.16 | 41.81 |
Raw materials | -377.89 | -263.23 | -242.02 | -215.28 |
As % of sales | 57.51 | 64.2 | 65.38 | 65.81 |
Employee costs | -34.54 | -28.43 | -24.61 | -21.65 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 118.81 | 32.45 | 24.16 | 22.68 |
Depreciation | -16.12 | -12.12 | -11.41 | -11.08 |
Tax paid | -35.71 | -9.95 | -7.85 | -7.49 |
Working capital | 78.78 | 14.98 | 9.66 | 26.86 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 60.23 | 10.76 | 13.16 | 41.81 |
Op profit growth | 184.93 | 12.24 | 8.66 | 27.97 |
EBIT growth | 226.77 | 20.85 | 6.55 | 39.23 |
Net profit growth | 269.37 | 37.94 | 7.4 | 94.08 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,727.5 | 96.95 | 4,14,533.1 | 2,000.46 | 0.93 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,790 | 81.58 | 1,80,214.67 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,490.9 | 25.02 | 1,20,427.63 | 1,485.4 | 1.07 | 4,254.47 | 397.39 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,439.6 | 61.52 | 1,16,404.77 | 474 | 0.17 | 2,385 | 224.34 |
Mankind Pharma Ltd MANKIND | 2,651 | 58.1 | 1,09,463.92 | 382.46 | 0 | 2,126.59 | 354.71 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Sanjankumar R Bajaj
Managing Director
Anil C Jain
Whole-time Director
Namrata S Bajaj
Whole-time Director
Dhananjay S Halte
Independent Director
Ram B Banarase
Independent Director
Hemant R Karnik
Independent Director
Loukik D Tipnis
Independent Director
Kejal Shah
Whole-time Director
Pakshal Jain
Company Sec. & Compli. Officer
MONICA TANWAR
Independent Director
Sandeep Shah
Independent Director
Yaqoob Ali
602-606 Bhoomi Velocity Infote,
Road No 23 Wagle Indl Estate,
Maharashtra - 400604
Tel: 91-22-66177400/401
Website: http://www.bajajhealth.com
Email: investors@bajajhealth.com
Unit No 1 Luthra Ind,
Andheri Kurla Road, Safed Pool Andheri(E,
Mumbai - 400 072
Tel: 91-22-2851 5606
Website: www.sharexindia.com
Email: sharexndia@vsnl.com
Summary
Incorporated in 1993, Maharashtra-based Bajaj Healthcare Limited is one of Indias large scale and vertically integrated pharmaceutical manufacturer for quality-conscious customers. The Company is enga...
Read More
Reports by Bajaj Healthcare Ltd
What is the Bajaj Healthcare Ltd share price today?
What is the Market Cap of Bajaj Healthcare Ltd?
What is the PE and PB ratio of Bajaj Healthcare Ltd?
What is the 52 Week High and Low of Bajaj Healthcare Ltd?
What is the CAGR of Bajaj Healthcare Ltd?
What is the shareholding pattern of Bajaj Healthcare Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
